通过PROTAC介导的维门丁降解促进了多能干细胞的末端红色球分化
Hao Yan1, Ruge Zang2, Tiantian Cui1
1Beijing Institute of Radiation Medicine, Beijing, 100850, P. R. China.
Stem cell research & therapy
|September 18, 2024
概括
人类多能干细胞衍生的红色素细胞中维门 (VIM) 的保留会损害核化. 使用PROTAC平台降解维门丁,通过增强核极化,加速红状腺核化.
科学领域:
- 干细胞生物学 干细胞生物学
- 血液形成 血液形成 血液形成
- 细胞分化的细胞分化.
背景情况:
- 人类多能干细胞 (hPSCs) 提供了红状腺细胞生成的来源.
- 从hPSC衍生的红细胞往往无法脱核,与带血的祖先不同.
- 维丁 (VIM) 保留在hPSC-红色素细胞中,但不在成熟的红细胞中,这表明它在核化缺陷中的作用.
研究的目的:
- 调查维门丁 (VIM) 在hPSCs的红状腺核化中的作用.
- 为了确定VIM保留是否会损害核分裂,并阐明底层机制.
- 评估VIM降解的潜力,以改善红状腺核化.
主要方法:
- 通过使用向蛋白解的嵌合体 (PROTAC) 建立了一个具有可逆VIM降解 (dTAG-VIM-H9) 的人类胚胎干细胞 (hESC) 线.
- 从CD34+带血和hESC衍生的有机物中进行了红质形成的时间过程研究.
- 利用形态分析,qRT-PCR,西部抹杀,流细胞计和高速成像来比较VIM表达细胞和VIM枯竭细胞.
主要成果:
- 维丁 (VIM) 表达在正常的红色素形成过程中减少,但在hESC衍生的红色素细胞中持续存在.
- 使用dTAG系统的VIM消耗显著促进了dTAG-VIM-H9细胞中的红状腺核化.
- 消除VIM增强了红细胞核极化,这是核化的一个关键步骤.
结论:
- 在hPSCs的红色素形成过程中,维丁 (VIM) 保留阻碍了红色素核化.
- 通过PROTAC dTAG系统的VIM降解加速了红状腺核化.
- 针对VIM降解提供了一个潜在的策略,以改善hPSCs功能性红细胞的生成.
相关概念视频
Maintenance of the ES Cell State
2.2K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.2K
Forced Transdifferentiation
1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
1.9K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Induced Pluripotent Stem Cells
21.9K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
21.9K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K


